Challenges in the Israeli Health-Tech Industry: A Sharp Decline in Investments in 2025
The medical technology (Health-Tech) industry in Israel is considered one of the most important engines of the local economy. However, a new report recently published presents a complex picture of the situation in the sector in 2025. On one hand, there is stability in the export of technologies abroad, but on the other hand, a significant decline in new investments has been recorded.
According to the data in the report, there has been a sharp decline of about 40% in investments in life sciences companies in Israel compared to previous years. This is a significant and worrying change, especially after a period of some recovery in 2024. Experts note that investors have become more cautious in choosing the companies in which they choose to invest their money.
In addition to the decline in total overall investments, the report points to another trend: the average amount per transaction has become smaller. This means that medical startups are finding it difficult to raise large sums of money as they did in the past, which could affect their ability to develop new products over time.
Despite these challenging figures, there is also a bright spot in the report. The export of medical products and technologies from Israel to global markets has remained stable. This figure shows that the world still values and consumes Israeli innovation in the healthcare field, and that products already on the market continue to succeed.
In conclusion, the Health-Tech industry in Israel is in a period of change. While demand for Israeli technology worldwide continues, the decline in investments requires local companies to become more efficient and find creative ways to grow. The government and the industry will need to closely monitor the data to maintain Israel's status as a global center for life sciences.